CN Patent

CN110184340A — 遗传性卵黄样营养不良新致病突变及其应用

Assigned to Eye and ENT Hospital of Fudan University · Expires 2019-08-30 · 7y expired

What this patent protects

本发明涉及遗传性卵黄样营养不良新致病突变及其应用。本发明基于临床资源，借助基因捕获芯片及深度测序技术，通过遗传学、结合临床表现及人群验证，成功证实所检测到的BEST1基因的14个突变位点为遗传性卵黄样营养不良新致病位点，为该疾病的诊断提供了新的分子生物学基础，基于所述的14个突变位点可以开发遗传性卵黄样营养不良的诊断试剂盒，提高临床诊断准确性。

USPTO Abstract

本发明涉及遗传性卵黄样营养不良新致病突变及其应用。本发明基于临床资源，借助基因捕获芯片及深度测序技术，通过遗传学、结合临床表现及人群验证，成功证实所检测到的BEST1基因的14个突变位点为遗传性卵黄样营养不良新致病位点，为该疾病的诊断提供了新的分子生物学基础，基于所述的14个突变位点可以开发遗传性卵黄样营养不良的诊断试剂盒，提高临床诊断准确性。

Drugs covered by this patent

Patent Metadata

Patent number
CN110184340A
Jurisdiction
CN
Classification
—
Expires
2019-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Eye and ENT Hospital of Fudan University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.